Violet Kasabri

1.6k total citations
107 papers, 1.2k citations indexed

About

Violet Kasabri is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Violet Kasabri has authored 107 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in Violet Kasabri's work include Natural Antidiabetic Agents Studies (23 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Pharmacology and Obesity Treatment (9 papers). Violet Kasabri is often cited by papers focused on Natural Antidiabetic Agents Studies (23 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Pharmacology and Obesity Treatment (9 papers). Violet Kasabri collaborates with scholars based in Jordan, Germany and Palestinian Territory. Violet Kasabri's co-authors include Fatma U. Afifi, Yasser Bustanji, Yusuf Al‐Hiari, Rana Abu‐Dahab, Imad I. Hamdan, Randa Naffa, Nailya Bulatova, Amal Akour, Ihab M. Almasri and Peter R. Flatt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Violet Kasabri

97 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violet Kasabri Jordan 20 384 279 275 149 145 107 1.2k
Worapaka Manosroi Thailand 25 451 1.2× 170 0.6× 276 1.0× 95 0.6× 203 1.4× 117 1.8k
Sivapragasam Gothai Malaysia 13 458 1.2× 386 1.4× 168 0.6× 150 1.0× 186 1.3× 24 1.5k
Khalid S. Al‐Numair Saudi Arabia 19 257 0.7× 215 0.8× 264 1.0× 92 0.6× 180 1.2× 77 1.1k
Ernest David India 21 276 0.7× 355 1.3× 255 0.9× 80 0.5× 160 1.1× 53 1.2k
Umesh Kumar Patil India 22 318 0.8× 379 1.4× 223 0.8× 127 0.9× 187 1.3× 123 1.6k
Alina Elena Pârvu Romania 22 306 0.8× 317 1.1× 116 0.4× 144 1.0× 163 1.1× 72 1.3k
Christudas Sunil United States 23 435 1.1× 392 1.4× 420 1.5× 148 1.0× 127 0.9× 41 1.4k
Pandurangan Subash‐Babu Saudi Arabia 18 340 0.9× 381 1.4× 337 1.2× 111 0.7× 231 1.6× 46 1.3k
Constant Anatole Pieme Cameroon 21 387 1.0× 473 1.7× 181 0.7× 89 0.6× 210 1.4× 84 1.4k
Riham A. El‐Shiekh Egypt 20 407 1.1× 283 1.0× 117 0.4× 167 1.1× 237 1.6× 139 1.3k

Countries citing papers authored by Violet Kasabri

Since Specialization
Citations

This map shows the geographic impact of Violet Kasabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violet Kasabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violet Kasabri more than expected).

Fields of papers citing papers by Violet Kasabri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violet Kasabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violet Kasabri. The network helps show where Violet Kasabri may publish in the future.

Co-authorship network of co-authors of Violet Kasabri

This figure shows the co-authorship network connecting the top 25 collaborators of Violet Kasabri. A scholar is included among the top collaborators of Violet Kasabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violet Kasabri. Violet Kasabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zahra, Jalal A., et al.. (2025). Multifunctional Aliphatic Diamine-Based Polynaphthoxazines: From Synthesis and Polymerization to Bioactivity and Photoluminescence. ACS Omega. 10(36). 41878–41889. 2 indexed citations
5.
Kasabri, Violet, et al.. (2022). Oxytocin, the panacea for long-COVID? a review. Hormone Molecular Biology and Clinical Investigation. 43(3). 363–371. 3 indexed citations
6.
Kasabri, Violet, et al.. (2021). Uric Acid Relationship with Noninsulin-Based Insulin Resistance Indices in Selected Metabolic Disorders: A Systematic Critical Review. Jordan Journal of Pharmaceutical Sciences. 14(3). 1 indexed citations
7.
Hudaib, Mohammad, et al.. (2020). Chemical Composition of Essential Oil and Screening of Antiproliferative Activity of Paronychia argentea Lam. Aerial Parts: an Ethno-Medicinal Plant from Jordan. Jordan Journal of Pharmaceutical Sciences. 13(3). 2 indexed citations
8.
Kasabri, Violet, et al.. (2020). Antilipolytic-Antiproliferative Activity of Novel Antidiabesity Triazolo/Fluoroquinolones. Jordan Journal of Pharmaceutical Sciences. 13(1). 7 indexed citations
9.
Bulatova, Nailya, et al.. (2019). Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes. Bratislavské lekárske listy/Bratislava medical journal. 119(12). 762–769. 6 indexed citations
10.
Alqaraleh, Moath, et al.. (2019). Branched amino acids as potential biomarkers in metabolic syndrome patients and as hypolipidemic compounds. Eurasian Journal of Biosciences. 13(2). 2233–2241. 2 indexed citations
12.
Albsoul‐Younes, Abla, et al.. (2019). Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes. Hormone Molecular Biology and Clinical Investigation. 37(3). 4 indexed citations
13.
Kasabri, Violet, et al.. (2018). Potential Antiproliferative Activity and Evaluation of Essential Oil Composition of the Aerial Parts of Tamarix aphylla (L.) H.Karst.: A Wild Grown Medicinal Plant in Jordan. Evidence-based Complementary and Alternative Medicine. 2018(1). 9363868–9363868. 11 indexed citations
14.
Suyagh, Maysa, Eman Alefishat, Rana Abu Farha, et al.. (2018). The Impact of Shift Work-Related Circadian Rhythm Disruption on Inflammatory Biomarkers. Jordan Journal of Pharmaceutical Sciences. 11(2). 2 indexed citations
16.
Kasabri, Violet, Nailya Bulatova, Amal Akour, et al.. (2017). Evaluation of correlations of Plasma Levels of Oxytocin, Omentin-1 and Irisin in Diabetic and Non-Diabetic Metabolic Syndrome Patients: A Cross Sectional Study in Jordan. Jordan Medical Journal. 51(3). 1 indexed citations
17.
El‐Elimat, Tamam, et al.. (2017). Phytochemical Screening and Pharmacological Activities of Echium judaeum Lacaita Extracts Growing Wild in Jordan. Jordan Journal of Pharmaceutical Sciences. 10(3). 3 indexed citations
18.
Kasabri, Violet, et al.. (2016). Evaluation of Oxytocin (OXT), Endothelin-1 and Nesfatin Plasma Concentrations in Newly-diagnosed Diabetic and Non-diabetic Patients with Metabolic Syndrome. Jordan Journal of Pharmaceutical Sciences. 9(3). 1 indexed citations
19.
Foddai, Marzia, Violet Kasabri, Fatma U. Afifi, et al.. (2014). In vitro inhibitory effects of Sardinian Pistacia lentiscus L. and Pistacia terebinthus L. on metabolic enzymes: Pancreatic lipase, α‐amylase, and α‐glucosidase. Starch - Stärke. 67(1-2). 204–212. 32 indexed citations
20.
Kasabri, Violet & Nailya Bulatova. (2010). Current View on Biology of Aging. Jordan Medical Journal. 44(2).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026